Brief: Theraclion: FDA Approves Pivotal Varicose Veins Study With Theraclion's Sonovein®
April 17 (Reuters) - Theraclion SA ALTHER.PA :
* FDA APPROVAL FOR PIVOTAL VARICOSE VEINS STUDY WITH
THERACLION’S
SONOVEIN®
Source text for Eikon: ID:nBw7Y87lva
Further company coverage: ALTHER.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Theraclion SA
See all newsBrief: Theraclion Appoints Claude Lenoir As Interim Chairman
Brief: Theraclion Secures U.S. Reimbursement Milestone for Sonovein With New Category III CPT Code
French and Benelux stocks-Factors to watch
Brief: Inner Mongolia Furui Medical Raises Stake In Theraclion
Brief: French medical technology company Theraclion strikes partnership with Chinese company Furui and names new CEO